Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.380
0.00 (0.00%)
May 18, 2026, 4:00 PM EDT - Market closed

CNTB Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
0.230.0626.03---
Revenue Growth (YoY)
-99.11%-99.75%----
Gross Profit
0.230.0626.03---
Selling, General & Admin
20.2720.3417.4316.0520.8119.01
Research & Development
46.237.827.865396.6380.5
Other Operating Expenses
-----1.08-1.85
Operating Expenses
66.4758.1445.2969.06116.3697.66
Operating Income
-66.23-58.07-19.25-69.06-116.36-97.66
Interest Expense
-----0.02-0.01
Interest & Investment Income
1.812.274.455.221.810.17
Currency Exchange Gain (Loss)
----1.47-0.52
Other Non Operating Income (Expenses)
0.010.522.591.85--103.98
EBT Excluding Unusual Items
-64.42-55.28-12.21-61.99-113.1-202
Asset Writedown
-----4.7-
Other Unusual Items
---3.2---
Pretax Income
-64.42-55.28-15.41-61.99-117.79-202
Income Tax Expense
0.190.20.220.120.30.27
Earnings From Continuing Operations
-64.61-55.48-15.63-62.11-118.09-202.27
Net Income
-64.61-55.48-15.63-62.11-118.09-202.27
Net Income to Common
-64.61-55.48-15.63-62.11-118.09-202.27
Shares Outstanding (Basic)
565655555552
Shares Outstanding (Diluted)
565655555552
Shares Change (YoY)
1.24%0.81%0.27%0.04%5.50%205.31%
EPS (Basic)
-1.15-1.00-0.28-1.13-2.15-3.88
EPS (Diluted)
-1.15-1.00-0.28-1.13-2.15-3.88
Free Cash Flow
-57.61-51.64-24.36-47.82-105.93-88.16
Free Cash Flow Per Share
-1.03-0.93-0.44-0.87-1.92-1.69
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-28426.61%-90740.63%-73.95%---
Profit Margin
-27727.90%-86687.50%-60.03%---
Free Cash Flow Margin
-24723.18%-80687.50%-93.58%---
EBITDA
-65.54-57.37-18.59-68.34-115.63-97.17
EBITDA Margin
---71.42%---
D&A For EBITDA
0.70.70.660.720.730.49
EBIT
-66.23-58.07-19.25-69.06-116.36-97.66
EBIT Margin
---73.95%---
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q